Cochrane · systematic review · CD009422
Vitamin E supplementation in people with cystic fibrosis
Okebukola, PO, Kansra, S, Barrett, J · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library
Cystic Fibrosis and Genetic DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
14
current version
GRADE rated
1
No studies
12
Included studies
NR
No studies 12 · 85.7%Ungraded 1 · 7.1%Very low 0 · 0%Low 1 · 7.1%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings: water‐soluble vitamin E compared with control for cystic fibrosis
Population: children and adults with cystic fibrosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Vitamin E total lipid ratio Summary of findings: water‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
Vitamin E levels in serum: umol/L Summary of findings: water‐soluble vitamin E vs control | MD 19.74 [13.48, 26] | 1 study · 45 participants | Low Downgraded: imprecision, indirectness |
Neuropathy due to vitamin E deficiency Summary of findings: water‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
Retinopathy due to vitamin E deficiency Summary of findings: water‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
BMI Summary of findings: water‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
Height Summary of findings: water‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
FEV1 % predicted: change from baseline Summary of findings: water‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
Summary of findings: fat‐soluble vitamin E compared with control for cystic fibrosis
Population: children and adults with cystic fibrosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Vitamin E total lipid ratio Summary of findings: fat‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
Vitamin E levels in serum: umol/l Summary of findings: fat‐soluble vitamin E vs control | no estimate extracted | 6 participants | Ungraded |
Neuropathy due to vitamin E deficiency Summary of findings: fat‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
Retinopathy due to vitamin E deficiency Summary of findings: fat‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
BMI Summary of findings: fat‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
Height Summary of findings: fat‐soluble vitamin E vs control | no estimate extracted | NR | No studies |
FEV1 % predicted: change from baseline Summary of findings: fat‐soluble vitamin E vs control | no estimate extracted | NR | No studies |